Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|March 1, 2006
Pharmacological management of renal fibrotic diseaseJens Gaedeke, Hans-H Neumayer, Harm Peters
Critical Care Medicine|April 11, 2008
Long-term outcomes after acute kidney injuryStanislao Morgera, Michael Schneider, Hans H Neumayer
Current Medicinal Chemistry|June 10, 2008
NO signaling through cGMP in renal tissue fibrosis and beyond: key pathway and novel therapeutic targetYingrui Wang-Rosenke, Hans-H Neumayer, Harm Peters
Transplantation|February 25, 2005
Novel mediators of FTY720 in human lymphocytesTorsten Böhler, Klemens Budde, Hans-H Neumayer, et al.
Transplantation|March 15, 2006
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?Franca Fleiner, Lutz Fritsche, Petra Glander, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 28, 2005
Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritisJens Gaedeke, Torsten Boehler, Klemens Budde, et al.
Clinical Nephrology|May 1, 2014
Evaluation of acid-base control, electrolyte balance, and filter patency of a Prismaflex-based regional citrate anticoagulation protocol for pre-dilution continuous veno-venous hemodiafiltrationDmytro Khadzhynov, Torsten Slowinski, Ina Lieker, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 10, 2004
FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptorsTorsten Böhler, Johannes Waiser, Manuela Schuetz, et al.
Journal of Hypertension|December 5, 2003
Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertensionLars Rothermund, Peter Kossmehl, Hans-H Neumayer, et al.
International Immunopharmacology|December 13, 2006
Differential effects of single dose FTY720 on CD62L+ B-cells in stable renal allograft recipientsTorsten Böhler, Manuela Schütz, Klemens Budde, et al.
Pageof 11